These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3011442)

  • 41. Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat.
    Valentin JP; Jover B; Maffre M; Bertolino F; Bessac AM; John GW
    Am J Hypertens; 1997 Sep; 10(9 Pt 1):1058-63. PubMed ID: 9324114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
    Brezinski ME; Darius H; Lefer AM
    Arzneimittelforschung; 1986 Mar; 36(3):464-6. PubMed ID: 3707665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.
    Takahashi K; Nammour TM; Fukunaga M; Ebert J; Morrow JD; Roberts LJ; Hoover RL; Badr KF
    J Clin Invest; 1992 Jul; 90(1):136-41. PubMed ID: 1386085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardium.
    Darius H; Osborne JA; Reibel DK; Lefer AM
    J Mol Cell Cardiol; 1987 Mar; 19(3):243-50. PubMed ID: 2439696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroprotective effects of thromboxane receptor antagonist SQ 29,548 after pilocarpine-induced status epilepticus in mice.
    Mello FK; Freitas ML; Souto NS; Zorzi VN; Moreira MP; Neuberger B; Costa KG; Fighera MR; Royes LF; Furian AF; Oliveira MS
    Epilepsy Res; 2020 Feb; 160():106277. PubMed ID: 32036236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective thromboxane A2 receptor blockade in experimental exercise-induced myocardial ischaemia in dogs.
    Thaulow E; Guth BD; Schulz R; Ross J
    Acta Physiol Scand; 1989 Jul; 136(3):321-30. PubMed ID: 2526449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.
    Grover GJ; Parham CS; Schumacher WA
    Basic Res Cardiol; 1991; 86(2):99-106. PubMed ID: 1831610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
    Furlan LE; Johnson G; Siegfried M; Lefer AM
    J Pharmacol Exp Ther; 1990 May; 253(2):525-9. PubMed ID: 2140129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activator.
    Grover GJ; Parham CS; Schumacher WA
    Am Heart J; 1991 Feb; 121(2 Pt 1):426-33. PubMed ID: 1825008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion.
    Egan JW; Griswold DE; Hillegass LM; Newton JF; Eckardt RD; Slivjak MJ; Smith EF
    Prostaglandins; 1989 May; 37(5):597-613. PubMed ID: 2544926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thromboxane A2 receptor antagonism prevents hormonal and cardiovascular responses to mineral acid infusion.
    Cudd TA; Wood CE
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1235-40. PubMed ID: 7977850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids.
    Lefer AM; Burke SE; Lepran I
    Can J Physiol Pharmacol; 1984 Dec; 62(12):1487-91. PubMed ID: 6241500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
    Filep JG; Fournier A; Földes-Filep E
    Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N; Johnson G; Siegfried MR; Lefer AM
    Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
    Spurney RF; Middleton JP; Raymond JR; Coffman TM
    Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thromboxane receptor blockade with SQ 30,741 improves post-ischemic myocardial function in anesthetized dogs.
    Grover GJ
    Proc Soc Exp Biol Med; 1989 Oct; 192(1):56-60. PubMed ID: 2529546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early prostaglandin release from the ischemic myocardium in the dog.
    Ogletree ML; Flynn JT; Feola M; Lefer AM
    Surg Gynecol Obstet; 1977 May; 144(5):734-40. PubMed ID: 850857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of the beneficial effect of dexamethasone on myocardial cell integrity in acure myocardial ischemia.
    Lefer AM; Crossley K; Grigonis G; Lefer DJ
    Basic Res Cardiol; 1980; 75(2):328-39. PubMed ID: 7396811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulating role for thromboxane in the tubuloglomerular feedback response in the rat.
    Welch WJ; Wilcox CS
    J Clin Invest; 1988 Jun; 81(6):1843-9. PubMed ID: 2968365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.